A Phase II Study of M2951 in SLE

NCT02975336 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

469

Enrollment

INDUSTRY

Sponsor class

Stopped Study is completed; primary analysis completed.

Conditions

Systemic Lupus Erythematosus

Interventions

DRUG: Placebo
DRUG: M2951
DRUG: M2951
DRUG: M2951
DRUG: M2951

Sponsor

EMD Serono Research & Development Institute, Inc.

Collaborators

[object Object]